Head-to-head dispatch
Amble vs VyrarX
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Telehealth weight loss provider offering compounded semaglutide and tiered tirzepatide programs.
Marked down on: Limited public information on program details
Desk Score
VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.
Marked down on: Tirzepatide at $329/month starting is at the high end of the compounded market
Amble takes this head-to-head with the higher Desk Score, 76/100 (C) against 67/100 (C) for VyrarX. VyrarX still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Amble
76/100
C
VyrarX
67/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Amble | VyrarX |
|---|---|---|
| Semaglutide | $179/mo (starting dose, compounded) | $179/mo (starting dose, compounded) |
| Tirzepatide | $289/mo (starting dose, compounded) | $329/mo (starting dose, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who want mainstream telehealth GLP-1 access. | Readers who want compounded semaglutide ($179/mo) and tirzepatide ($329/mo) via LegitScript-certified telehealth in 47 states. |
| Desk Score | 76/100C | 67/100C |
The verdict
Desk pick — AmbleAmble takes this head-to-head with the higher Desk Score, 76/100 (C) against 67/100 (C) for VyrarX. VyrarX still holds its ground where its strengths line up with yours.
Choose Amble if…
Readers who want mainstream telehealth GLP-1 access.
$179/mo (starting dose, compounded) sema · $289/mo (starting dose, compounded) tirz · All 50 states
Choose VyrarX if…
Readers who want compounded semaglutide ($179/mo) and tirzepatide ($329/mo) via LegitScript-certified telehealth in 47 states.
$179/mo (starting dose, compounded) sema · $329/mo (starting dose, compounded) tirz · Coverage not published
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Amble · VyrarX.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Amble vs CoreAge Rx
- VyrarX vs Vaylen
- Amble vs Strut Health
- VyrarX vs Ondra Health
- Amble vs Invigor Medical
- VyrarX vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.